randomized double-blind placebo-controlled trial of acetyl-l-carnitine for als A randomized, double-blind, placebo-controlled, phase IIa, clinical study on investigating the efficacy and safety SPH3127 tablet in patients with essential hypertension The Scientific and Therapeutic Rationale
The Scientific and Therapeutic Rationale for OffLabel Treatments in Amyotrophic Lateral Sclerosis Bedlack 2025 Annals of Neurology Wiley Online Library The effects of l Carnitine supplementation on inflammatory markers, clinical status, and 28 days mortality in critically ill patients: A double blind, randomized, placebo controlled trial Clinical Nutrition ESPEN PDF) Acetyl L Carnitine (ALC) in Attention Deficit Hyperactivity Disorder: A Multi Site, Placebo Controlled Pilot Trial In the randomized, double blind, placebo controlled, global Phase III trial recently presented in the ASCO 2024 annual meeting, consolidation treatment with #durvalumab significantly improved clinical outcomes for patients with limited stage small cell Efficacy of mecasin for treatment of amyotrophic lateral sclerosis: A phase IIa multicenter randomized double blinded placebo controlled trial ScienceDirect
Pay in 4 interest-free payments of $7.34 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9



